About BioKey

A Leader in Innovative Oral Controlled Release Technologies


Biokey’s core expertise is applying its proprietary oral controlled release technologies to develop especially generic, branded pharmaceutical, botanical, and nutraceutical products.

About BioKey

  • BioKey provides its clients with integrated pharmaceutical services including early phase product development, formulation development, analytical development & drug product manufacturing.
  • More than 10 products are under development at BioKey, four ANDAs were approved by US-FDA in the past.

BioKey’s Business Model

  • Serve clients as a cDMO for companies in USA, Asia & Canada – Formulation development, cGMP CTM at all phases, US-FDA registration & export manufacturing to Asia
  • Co-develop products with companies in Asia /US & Canada and bring products to these countries – develop dosage form, GMP material at all phases, sponsor clinical trials and manufacturing with partner companies.
  • Develop dosage form products with pilot human safety/PK-PD & efficacy data and out license to partner companies
  • Integrated pharmaceutical services

BioKey's facilities are cGMP certified.